Home › Meningioma › Washington › Seattle
Meningioma clinical trials in Seattle, WA
3 studies for Meningioma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- and 1 more
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- Virginia Mason, Seattle
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
Meningioma trials in other cities
- New York City, NY8 studies
- Miami, FL8 studies
- Columbus, OH7 studies
- Boston, MA7 studies
- Atlanta, GA6 studies
- San Francisco, CA6 studies
- Jacksonville, FL5 studies
- San Diego, CA5 studies
- St. Louis, MO4 studies
- Arlington, VA4 studies
- Houston, TX4 studies
- Phoenix, AZ4 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Prostate Cancer44 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.